WASHINGTON — On Tuesday, the Trump administration celebrated drug price cuts it had secured through a Democrat-created program — despite Republicans’ longstanding antipathy toward the policy.

The Inflation Reduction Act, a 2022 law supported solely by Democrats and signed into law by then-President Biden, allowed the Trump administration to secure lower prices on 15 drugs for Medicare recipients, including popular GLP-1s like Wegovy and Ozempic.

Centers for Medicare and Medicaid Services Director Mehmet Oz bragged that the latest round of negotiations yielded even greater price cuts than the Biden administration scored last year, when officials set prices for 10 medications. Oz said the Trump administration had used “the same process with a bolder direction,” adding the Biden adminis

See Full Page